Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
GNGenprex, Inc. logo

Genprex, Inc. (GNPX)

NASDAQ Capital Market · Currency in USD
$1.81 ▼ -0.17 (-8.59%)
At close: Oct 23, 4:00 PM ET. Market closed.
$1.84 ▲ +0.03 (+1.66%)
After hours: Oct 23, 7:59 PM ET

Summary

Previous Close
$1.98
Open
$2.08
Day's Range
$1.79 – $2.08
52 Week Range
$1.79 – $217.60
Volume
211,856
Avg. Volume
206,334
Market Cap
$913.93K
Beta (5Y Monthly)
-0.98
PE Ratio (TTM)
--
EPS (TTM)
-$34.87
Earnings Date
Dec 2, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Genprex, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
13
CEO
Ryan Confer

Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer and small cell lung cancer.

Earnings

Next report: Wed, Dec 2, 2026
EPS estimate -$6,160.00
DateEst.Actual
Aug 14, 2026–-$9.40
May 13, 2026–-$14.07
Mar 30, 2026-$286.00-$25.30Beat
Nov 14, 2025-$275.00-$109.89Beat
Aug 8, 2025-$15.62-$187.00Miss
May 12, 2025-$55.88-$285.71Miss

Analyst view

Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on GNPX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.